Fintel reports that on May 13, 2025, Leerink Partners downgraded their outlook for Halozyme Therapeutics (NasdaqGS:HALO) from ...

Johnson & Johnson (NYSE:JNJ) stock and Halozyme (HALO) stock were downgraded at Leerink Partners on earlier than expected price controls for products. Read more here.

Halozyme Therapeutics shares tumbled Tuesday on a new Medicare approach to price negotiations for drugs that use additive ...

Despite Halozyme reporting generally positive first-quarter results, the stock was negatively impacted by the potential risk that its hyaluronidase combination products may face earlier price ...

Stocks are mixed midday following upbeat inflation data, with the S&P 500 Index (SPX) breaking into positive territory for 2025 ...

The broad market index advanced 0.72% to close at 5,886.55. The S&P 500 now has a gain of 0.08% in 2025. The Nasdaq Composite ...

The annual inflation rate in the US slowed to 2.3% in April from 2.4% in the previous month and versus market estimates of ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

After months of turbulence in the skies of global trade, Boeing (BA) is finally seeing clearer weather in one of its most ...

Biggest stock gainers. Coinbase (NASDAQ:COIN) +11% — Shares jumped after S&P Dow Jones Indices announced the crypto exchange ...

FacebookTweetPin AI and growth stocks in general have continued extending their gains so far today after the CPI report ...